Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembo...
In the RECORD studies, considering death, symptomatic venous thromboembolism, and major bleeding, rivaroxaban resulted in greater benefits than harms compared with enoxaparin. When incorporating...
pubmed.ncbi.nlm.nih.gov